This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Overview of Research Design: The purposes of this study are to evaluate, in frail elderly hip fracture patients, the effects of exercise training combined with testosterone therapy on measures of skeletal mass, muscle strength and functional capacity, bone mineral density, quality of life, and self-report of ADL performance. We will utilize many of the facilities currently available through the Washington University (WU) Division of Geriatrics and Gerontology, General Clinical Research Center, and the Program in Physical Theray. Eighty-eight community-dwelling post-hip fracture patients aged 65 and over will be recruited from area hospitals and home care programs to participate in a randomized, double-blind, placebo-controlled trial of exercise training and testosterone therapy. Participants will enroll in the study upon completion of standard physical therapy (12-16 weeks post fracture) because enrollment during the immediate post fracture period is not feasible, conflicts with standard care practicec, and may introduce greater risks. All participants will perform an exercise-training program that will consist of 2 months of flexibility, balance, walking and light resistance exercises, followed by 4 months of progressive resistance training. Participants will be randomly assigned to take testosterone in the forma of a 1% topical gel, or an identical placebo gel, for 6 months. Outcome measurements will be obtained at baseline and after 2 and 6 months of the intervention. The primary study outcome measures will be thigh muscle cross-sectional mass (by 1H-MRI), total lean body mass as measured by DXA, measures of skeletal muscle strength, and total score for an objective Physical Performance Test. Seconday outcome meausres will be bone mineral density (BMD, by DXA), measurements of balance, gait, peak aerobic power, self-report of performance of ADLs, mood, and quality of life. Rationale for a 2-group design with exercise training: Some may argue that we should employ a 4-group design for this trial in order to evaluate the independent effects of testosterone therapy and exercise training, or evaluate testosterone with a home exercise program. The recruitment demands of a 4-group trial are not feasible at this stage, and would probably require a multi-center trial. We are proposing to evaluate the effects of testosterone combined with exercise because preliminary data from our ongoing study suggest that although exercise training is superior to home exercise in reversing physical impairments in hip fracture patients, many subjects remain frail. A combined approach may be required to achieve maximal improvements in muscle mass and strenght and related physical impairments, and to reduce the risk of persistant disability. Data from studies of testosterone in men suggest that androgen therapy combined wtih exercise training has additive effects on muscle strength and body composition.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
General Clinical Research Centers Program (M01)
Project #
5M01RR000036-46
Application #
7377199
Study Section
Special Emphasis Panel (ZRR1-CR-4 (02))
Project Start
2006-04-01
Project End
2007-03-31
Budget Start
2006-04-01
Budget End
2007-03-31
Support Year
46
Fiscal Year
2006
Total Cost
$7,913
Indirect Cost
Name
Washington University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Kelsey, Megan M; Braffett, Barbara H; Geffner, Mitchell E et al. (2018) Menstrual Dysfunction in Girls From the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study. J Clin Endocrinol Metab 103:2309-2318
Kleinberger, Jeffrey W; Copeland, Kenneth C; Gandica, Rachelle G et al. (2018) Monogenic diabetes in overweight and obese youth diagnosed with type 2 diabetes: the TODAY clinical trial. Genet Med 20:583-590
Berkowitz, Robert I; Marcus, Marsha D; Anderson, Barbara J et al. (2018) Adherence to a lifestyle program for youth with type 2 diabetes and its association with treatment outcome in the TODAY clinical trial. Pediatr Diabetes 19:191-198
Arslanian, Silva; El Ghormli, Laure; Kim, Joon Young et al. (2018) The Shape of the Glucose Response Curve During an Oral Glucose Tolerance Test: Forerunner of Heightened Glycemic Failure Rates and Accelerated Decline in ?-Cell Function in TODAY. Diabetes Care :
Kriska, Andrea; El Ghormli, Laure; Copeland, Kenneth C et al. (2018) Impact of lifestyle behavior change on glycemic control in youth with type 2 diabetes. Pediatr Diabetes 19:36-44
Venditti, E M; Tan, K; Chang, N et al. (2018) Barriers and strategies for oral medication adherence among children and adolescents with Type 2 diabetes. Diabetes Res Clin Pract 139:24-31
Gidding, Samuel S; Bacha, Fida; Bjornstad, Petter et al. (2018) Cardiac Biomarkers in Youth with Type 2 Diabetes Mellitus: Results from the TODAY Study. J Pediatr 192:86-92.e5
Yoon, Hyejin; Belmonte, Krystal C; Kasten, Tom et al. (2017) Intra- and Inter-individual Variability of microRNA Levels in Human Cerebrospinal Fluid: Critical Implications for Biomarker Discovery. Sci Rep 7:12720
Park, H-W; Tse, S; Yang, W et al. (2017) A genetic factor associated with low final bone mineral density in children after a long-term glucocorticoids treatment. Pharmacogenomics J 17:180-185
Bertozzi, Beatrice; Tosti, Valeria; Fontana, Luigi (2017) Beyond Calories: An Integrated Approach to Promote Health, Longevity, and Well-Being. Gerontology 63:13-19

Showing the most recent 10 out of 497 publications